McKesson's second-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical ...

U.S. stocks are ticking higher ahead of the Federal Reserve’s announcement coming later in the afternoon about what it will ...

Steve Baxter, an analyst from Wells Fargo, maintained the Hold rating on McKesson (MCK – Research Report). The associated price target ...

The Dow Jones Industrial Average fell 62 points, or 0.1 percent, while the Nasdaq composite rose 0.7 percent. McKesson, a ...

McKesson's earnings for its fiscal 2025 second quarter exceeded expectations, despite special charges that cut into net ...

McKesson MCK reported better-than-expected second-quarter financial results on Wednesday. McKesson reported quarterly earnings of $7.07 per share which beat the analyst consensus estimate of $6.88 per ...

McKesson Corporation ( (MCK) ) has released its Q2 earnings. Here is a breakdown of the information McKesson Corporation presented to its ...

McKesson (MCK) stock traded higher as Baird upgraded the company to outperform citing its Core Ventures deal and its strong Q2 FY25 earnings. Read more here.

McKesson Corporation (NYSE: MCK) has released its fiscal 2025 second quarter financial results. Results can be accessed on McKesson’s Investor Relatio ...

Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S.